Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?

dc.contributor.author	Strouse, John J
dc.coverage.spatial	United States
dc.date.accessioned	2016-12-01T14:23:33Z
dc.date.issued	2015-06
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/25755219
dc.identifier.eissn	1545-5017
dc.identifier.uri	https://hdl.handle.net/10161/13040
dc.language	eng
dc.publisher	Wiley
dc.relation.ispartof	Pediatr Blood Cancer
dc.relation.isversionof	10.1002/pbc.25471
dc.subject	Adult
dc.subject	Anemia, Sickle Cell
dc.subject	Child
dc.subject	Humans
dc.subject	Hydroxyurea
dc.title	Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?
dc.type	Journal article
duke.contributor.orcid	Strouse, John J\|0000-0003-0341-1457
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/25755219
pubs.begin-page	929
pubs.end-page	930
pubs.issue	6
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Duke
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, Hematology
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	62

Files

Now showing 1 - 1 of 1